Health
Eli Lilly's Weight Loss Drug Cuts Diabetes Risk by 94% in Long-Term Trial
Eli Lilly's weight loss drug, tirzepatide, has shown promising results in reducing the risk of developing type 2 diabetes by 94% in obese or overweight adults with pre-diabetes. This data comes from a three-year follow-up of the late-stage trial known as SURMOUNT-1. The study, which included over 1,